Oncologists in the Netherlands will judge new cancer medicines more strictly before prescribing them to patients, according to new guidelines from the committee of Dutch oncologists and pulmonologists. In terminally ill patients with a life expectancy of a year or more, a drug must extend their life by at least four months instead of the current three months. Patient federations are livid, the Volkskrant reports.